This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Rick Pearson

Senior Contributor to TheStreet

Rick Pearson is an activist investor focused on US listed stocks in the US and in China.  He was previously an investment banker in one of Wall Street's largest investment banks for nearly a decade, stationed between New York, Hong Kong and London. As a Director in Equity Capital Markets he oversaw over $30 billion in equity and equity linked transactions, primarily for Healthcare and Technology companies. Mr. Pearson spends his time living between Los Angeles and Beijing, China. He graduated magna cum laude from The University of Southern California with a degree in Finance and has studied Mandarin since 1991. Mr. Pearson has had over 200 articles published in various locations discussing investment considerations and due diligience issues with US listed securities.

Rick Pearson
By This Author:
« Back
Page 1 of 9
Article

3 Oncology Biotechs to Watch

By Rick Pearson

Handicapping the potential of Galena Biopharma, CytRx and Northwest Biotherapeutics requires a solid understanding of what has been driving share prices.

09:21AM 01/27/14

Article

Best Trade for Renewable Energy Is Short

By Rick Pearson

Though Renewable Energy's Tuesday's acquisition of Syntroleum is puzzling, it is easy to see why REGI, PLUG and other new energy stocks could be set for sharp drops.

09:29AM 12/18/13

Article

Napco, Lionbridge: 2 Small-Caps Making Big Moves

By Rick Pearson

Some of the best investment calls in 2013 have been among small-mid cap tech and healthcare stocks trading for $5-$10 with medium-term catalysts.

06:00AM 12/13/13

Article

A Closer Look at Quest Diagnostics, Lab Corp and Hologic

By Rick Pearson

Obamacare may not these diagnostic stocks higher, but it is likely to give them meaningful boosts in revenue.

06:00AM 10/24/13

Article

Watch for a Big Short Squeeze in Cleantech Solutions

By Rick Pearson

With short interest rising and the potential for a strong earnings announcement, CleanTech could soon re-test its high for the year of around $11.

05:30AM 10/22/13

Article

Watch CodeSmart Reap Revenue Windfall

By Rick Pearson

Expect a sharp move upward for CodeSmart in a few weeks when it reports its first major revenue.

05:00AM 10/18/13

Article

Biozone: A Little Biotech Setting Up for Big Gains

By Rick Pearson

Biozone is very likely to look like a no-brainer by year-end.

10:08AM 10/10/13

Article

Beware the Chinese Rumor Mill

By Rick Pearson

Watch out for the companies that reverse-split to avoid delisting and then are the subject of explosive rumors. They are rife for manipulation.

11:21AM 06/07/13

Article

K12's Troubles Mounting in the U.S.

By Rick Pearson

The online education provider has run into a stream of lawsuits and negative media reports about its practices.

12:48PM 02/27/12

Article

Fraud Claims Dog QIHU

By Rick Pearson

Ad activity on its Web site indicates a problem with revenue numbers, adding to doubts swirling around the company.

10:16AM 02/03/12

« Back
Page 1 of 9

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs